Natalie V. Hoffmann

Natalie V. Hoffmann

Auto-generated profile, based on publicly available information

Natalie V. Hoffmann

Division of Pediatric Gastroenterology, Hepatology, and Nutrition Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
ETErin Toaz
Erin Toaz
ECEric Cheon
Eric Cheon
NHNatalie V. Hoffmann
Natalie V. Hoffmann
JPJohn E. Pandolfino
John E. Pandolfino
DCDustin A Carlson
Dustin A Carlson
JWJoshua B. Wechsler
Joshua B. Wechsler

17 November 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
ETErin Toaz
Erin Toaz
ABAlain J. Benitez
Alain J. Benitez
ECEric C. Cheon
Eric C. Cheon
MMMark Mahon
Mark Mahon
NHNatalie V. Hoffmann
Natalie V. Hoffmann
JWJoshua B. Wechsler
Joshua B. Wechsler
INTRODUCTION: Functional lumen imaging probe (FLIP) can assess the esophageal contractile response (CR). Anesthetic agents used during endoscopy affect esophageal contractility, however, the time or dose-dependent effect of specific medications on the esophageal CR in children is unknown. METHODS: Charts of patients aged 3–22 years undergoing endoscopy with FLIP for evaluation of dysphagia at 2 tertiary pediatric hospitals were reviewed. Anesthetic dose and timing were collected. FLIP data were exported to Wklytics to generate Panometry plots, and the CR was classified as normal, borderline, spastic, impaired, or absent based on established definitions. Binary logistic regression was performed to assess whether anesthetic administration was associated with absent CR. End-tidal sevoflurane concentration was compared across groups with normal, borderline, and absent/impaired CR. RESULTS: Three hundred-three pediatric patients with a mean (SD) age of 13 years (4), 65% adolescent boys, were included. Totally, 80 (26%) had abnormal esophageal CR, where 16 (5%) were impaired, 63 (21%) were absent, and 1 was spastic. Two hundred twenty-eight (75%) were diagnosed with eosinophilic esophagitis, and 215 (71%) received sevoflurane. The odds ratio for absent CR if sevoflurane was administered was 8.4 ( P < 0.001). Sevoflurane was used significantly more often for both induction and maintenance in patients with abnormal CR compared with normal CR (70% vs 38%, P < 0.001). During the maintenance phase of anesthesia, end-tidal sevoflurane concentration was higher in patients with abnormal CR compared with normal CR independent of propofol infusion, recruitment site, and distensibility. DISCUSSION: The timing and dose of sevoflurane is strongly associated with esophageal CR impairment during FLIP.

9 August 2024 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
AEAndrew Ebanks
Andrew Ebanks
MWMing-Yu Wang
Ming-Yu Wang
NHNatalie Hoffmann
Natalie Hoffmann
BWBarry K Wershil
Barry K Wershil
JWJoshua B Wechsler
Joshua B Wechsler
Intraepithelial mast cells (MCs) are increased in eosinophilic esophagitis (EoE) and reduced with elimination of dietary antigens. Single food reintroduction can identify triggers of eosinophilia; however, the extent to which specific foods trigger intraepithelial mastocytosis remains unknown. We hypothesized that specific foods drive different degrees of MC inflammation. We previously reported a prospective pediatric EoE cohort treated with a 4-food elimination diet (4FED) with removal of soy, egg, wheat, and milk. We retrieved unstained slides in which baseline, 4FED, and post-4FED diet reintroduction time points were available. Slides were stained with tryptase, and intraepithelial MCs were counted. Comparisons were made by stratifying patients by eosinophilia, basal cell hyperplasia (BCH), endoscopic abnormalities, and symptoms. Pearson correlation was assessed for MCs with eosinophilic, endoscopic, and BCH severity; symptoms; and a novel mucosal activity score combining endoscopic and histologic structural severity. Slides were available from 37 patients with at least 1 food reintroduced. MCs were significantly reduced with 4FED. Wheat led to increased intraepithelial MCs in the upper esophagus and with food-induced eosinophilia, while milk led to significantly increased MCs in the upper and lower esophagus and was significantly associated with patients with food-triggered eosinophilia, endoscopic abnormalities, BCH, and symptoms. MCs best correlated with the mucosal activity score during milk reintroduction. In children with EoE, MCs are reduced with 4FED. During milk reintroduction, significant increases in MCs were observed with all metrics of inflammation along with moderate correlation with structural mucosal activity that was not seen with other foods. This suggests that milk exerts unique effects either directly or indirectly on MCs in the esophagus in EoE patients.

2 April 2026 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
POPeter T. Osgood
Peter T. Osgood
NHNatalie V. Hoffmann
Natalie V. Hoffmann
JWJoshua B. Wechsler
Joshua B. Wechsler
RPRoman Pantazopoulos
Roman Pantazopoulos
JFJohn E. Fortunato
John E. Fortunato
Background & Aims: Pyloric dysfunction contributes to chronic nausea, vomiting, and abdominal pain in adults and children. The Functional Luminal Imaging Probe (FLIP) has been used in adults to characterize pyloric distensibility as a marker of muscular hypertonicity and to predict symptomatic improvement to intrapyloric botulinum toxin injection (IPBI). FLIP parameters that identify pyloric dysfunction in children are unknown. In this retrospective cohort study, we aimed to characterize the relationship of pyloric FLIP parameters to clinical symptoms, gastric emptying (GE), and antroduodenal manometry (ADM) findings in pediatric patients. Secondarily, we aimed to assess FLIP metrics as related to the subjective response to IPBI. Methods: Chart review was performed for patients undergoing pyloric FLIP for refractory upper gastrointestinal symptoms at Lurie Children's Hospital. FLIP parameters were compared to symptoms, demographics, medical history, GE, ADM findings, and documented response to IPBI. The presence of a distensibility plateau (DP) was assessed. Results: Ninety‐nine patients underwent pyloric FLIP and 74 were treated with IPBI. Pyloric distensibility index (pDI) correlated with age and biological gender. Patients with chronic nausea, early satiety, concurrent pain disorders, joint hypermobility, and orthostatic intolerance demonstrated higher pDI compared to other symptoms. While pDI did not correlate with GE, it was lower in patients with normal fasting patterns on ADM and higher in IPBI responders. Nearly half of patients demonstrated a DP for which pDI was significantly higher in IPBI responders. Conclusions: This pilot study supports pyloric dysfunction as a mechanism underlying chronic upper gastrointestinal symptoms and would support prospective investigation of pyloric FLIP metrics in pediatrics.

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
NHNatalie V. Hoffmann
Natalie V. Hoffmann
POPeter T. Osgood
Peter T. Osgood
JFJohn E. Fortunato
John E. Fortunato